Screener
Upstream Bio, Inc. UPB Total Current Liabilities
Total Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by Upstream Bio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.
The source filing: Upstream Bio, Inc.’s 10-Q, filed August 11, 2026.
- Filed
- Aug 11, 2026, 7:10 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-343417
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Accounts payable | $2,314 | $2,726 |
| Accrued expenses and other current liabilities | 6,946 | 10,006 |
| Operating lease liabilities, current portion | 728 | 720 |
| Total current liabilities | 9,988 | 13,452 |
| Operating lease liabilities, net of current portion | 226 | 549 |
| Total liabilities | 10,214 | 14,001 |
| Commitments and contingencies (Note 12) | ||
| Stockholders’ equity: |
Item 1. Financial Statements.
FAQ
- What is Upstream Bio, Inc.'s total current liabilities?
- Upstream Bio, Inc. (UPB) reported total current liabilities of $9.99M in Q2 2026.
- How has Upstream Bio, Inc.'s total current liabilities changed year-over-year?
- Upstream Bio, Inc.'s total current liabilities decreased by 8.6% year-over-year, from $10.93M to $9.99M.
- What is the long-term trend for Upstream Bio, Inc.'s total current liabilities?
- Over 2 years (2023 to 2025), Upstream Bio, Inc.'s total current liabilities has grown at a 43.7% compound annual growth rate (CAGR), from $6.52M to $13.45M.
- What does total current liabilities mean?
- The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.
Ask your AI about Upstream Bio, Inc.'s total current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude